<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title>how can we control drug nanoparticle crystallinity? | Lucas Attia</title> <meta name="author" content="Lucas Attia"> <meta name="description" content="understanding drug nanoparticle structure using molecular simulations"> <meta name="keywords" content="jekyll, jekyll-theme, academic-website, portfolio-website"> <link href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.1/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha256-DF7Zhf293AJxJNTmh5zhoYYIMs2oXitRfBjY+9L//AY=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="https://unpkg.com/bootstrap-table@1.21.4/dist/bootstrap-table.min.css"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.4.0/css/all.min.css" integrity="sha256-HtsXJanqjKTc8vVQjO4YMhiqFoXkfBsjBWcX91T1jr8=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha256-i1+4qU2G2860dGGIOJscdC30s9beBXjFfzjWLjBRsBg=" crossorigin="anonymous"> <link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jwarby/jekyll-pygments-themes@master/github.css" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="/assets/img/favicon.png"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://lucasattia.github.io/projects/6_project/"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jwarby/jekyll-pygments-themes@master/native.css" media="none" id="highlight_theme_dark"> <script src="/assets/js/theme.js?96d6b3e1c3604aca8b6134c7afdd5db6"></script> <script src="/assets/js/dark_mode.js?9b17307bb950ffa2e34be0227f53558f"></script> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="/"><span class="font-weight-bold">Lucas </span>Attia</a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item "> <a class="nav-link" href="/">about</a> </li> <li class="nav-item "> <a class="nav-link" href="/blog/">news</a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications</a> </li> <li class="nav-item "> <a class="nav-link" href="/projects/">projects</a> </li> <li class="nav-item "> <a class="nav-link" href="/repositories/">repositories</a> </li> <li class="nav-item "> <a class="nav-link" href="/assets/pdf/Lucas_Attia_CV_7_7_2025.pdf">cv</a> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="fas fa-moon"></i> <i class="fas fa-sun"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5"> <div class="post"> <header class="post-header"> <h1 class="post-title">how can we control drug nanoparticle crystallinity?</h1> <p class="post-description">understanding drug nanoparticle structure using molecular simulations</p> </header> <article> <p>This paper was the second in my PhD, and was a really exciting foray into using molecular dynamics simulations to understand material systems. A previous PhD student had observed that when we make drug nanoparticles using the technology my group has developed, the ‘crystallinity’ (or percentage of the nanoparticle that is crystalline vs. amorphous, see the image below) was extremely difficult to control.</p> <figure> <picture> <source class="responsive-img-srcset" media="(max-width: 480px)" srcset="/assets/img/crystallinity-480.webp"></source> <source class="responsive-img-srcset" media="(max-width: 800px)" srcset="/assets/img/crystallinity-800.webp"></source> <source class="responsive-img-srcset" media="(max-width: 1400px)" srcset="/assets/img/crystallinity-1400.webp"></source> <img src="/assets/img/crystallinity.png" class="img-fluid rounded z-depth-1 mx-auto d-block" width="auto" height="auto" title="Crystallinty" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> <p>Crystallinity is crucial to drug formulation because it impacts how quickly a drug dissolves, which directly affects its bioavailability—the extent to which the active drug is absorbed and becomes available in the body. So, the lack of control we observed experimentally posed a challenge that we wanted to understand and ultimately mitigate. Since we were looking at molecular-scale interactions, I turned to molecular dynamics simulations (using GROMACS) to understand what interactions governed this behavior. We modeled our system by building a nanocrystal surface of our drug, then treating that surface with different ratios of excipients.</p> <figure> <picture> <source class="responsive-img-srcset" media="(max-width: 480px)" srcset="/assets/img/simulate-480.webp"></source> <source class="responsive-img-srcset" media="(max-width: 800px)" srcset="/assets/img/simulate-800.webp"></source> <source class="responsive-img-srcset" media="(max-width: 1400px)" srcset="/assets/img/simulate-1400.webp"></source> <img src="/assets/img/simulate.png" class="img-fluid rounded z-depth-1 mx-auto d-block" width="auto" height="auto" title="simulation" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> <p>We looked at how the structure of the nanocrystal responded to these different treatments to understand the molecular-level driver of crystallinity in these nanoparticles. One of my favorite parts of this project is the crystallinity metric we defined to quantify the degree of crystallinity in the simulation. This was a challenging task, and no one has really established a good way to do this. We decided to base the metric from the <a href="https://www.compchems.com/what-is-the-rmsd-and-how-to-compute-it-with-gromacs/" rel="external nofollow noopener" target="_blank">RMSD</a>- which basically describes the amount of deviation of the atoms in the nanoparticle from their original lattice positions. We time-average the RMSD (since it can vary quite rapidly during the simulation), and normalize the value for any given simulation against the minimum deviation (RMSD for a simulation with no excipients), and the maximum deviation (the spacing between molecules in the lattice). This is summarized in the equation below. <br> \(\Gamma_{\text{effective}}= \frac{\frac{a}{2} - \langle \text{RMSD} \rangle}{\frac{a}{2} - \langle \text{RMSD}_{0} \rangle}\)<br> We discovered that two phenomena drive the crystallinity result of the surface. First, we find that the surfactant and polymer excipients we use experimentally compete at the interface, since both are surface active. However, since the surfactant is more surface active, it can outcompete the polymer, even at low concentrations, and ‘protect’ the surface from de-stabilizing polymer interactions. Additionally, the surfactant and polymer can themselves complex (a <a href="https://pubs.acs.org/doi/pdf/10.1021/la00022a026?casa_token=kONkmMNElfcAAAAA:Yj3PE_TvPQXbxuhaA8STo8VxnfCAplcXX3S5bkmY6juMhgh7LOix7kS9x4aWR7PNMEDSEpahSETJLg" rel="external nofollow noopener" target="_blank">well-studied phenomena in soft materials</a>), which de-localizes the polymer from the drug surface, and prevents it from disrupting the crystal structure and amorphizing the surface.</p> </article> <h2>References</h2> <div class="publications"> <h2 class="bibliography">2024</h2> <ol class="bibliography"><li> <div class="row"> <div class="col-sm-2 preview"> <figure> <picture> <source class="responsive-img-srcset" media="(max-width: 480px)" srcset="/assets/img/publication_preview/TOC_ami-480.webp"></source> <source class="responsive-img-srcset" media="(max-width: 800px)" srcset="/assets/img/publication_preview/TOC_ami-800.webp"></source> <source class="responsive-img-srcset" media="(max-width: 1400px)" srcset="/assets/img/publication_preview/TOC_ami-1400.webp"></source> <img src="/assets/img/publication_preview/TOC_ami.png" class="preview z-depth-1 rounded" width="auto" height="auto" alt="TOC_ami.png" data-zoomable onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> <div id="Attia2024-qn" class="col-sm-8"> <div class="title">Surfactant-Polymer Complexation and Competition on Drug Nanocrystal Surfaces Control Crystallinity</div> <div class="author"> <em>Lucas Attia</em>, Dien Nguyen, Devashish Gokhale, and <span class="more-authors" title="click to view 2 more authors" onclick=" var element=$(this); element.attr('title', ''); var more_authors_text=element.text() == '2 more authors' ? 'Talia Zheng, Patrick S Doyle' : '2 more authors'; var cursorPosition=0; var textAdder=setInterval(function(){ element.text(more_authors_text.substring(0, cursorPosition + 1)); if (++cursorPosition == more_authors_text.length){ clearInterval(textAdder); } }, '10'); ">2 more authors</span> </div> <div class="periodical"> <em>ACS Appl. Mater. Interfaces</em>, Jul 2024 </div> <div class="periodical"> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a href="/assets/pdf/attia-et-al-2024-surfactant-polymer-complexation-and-competition-on-drug-nanocrystal-surfaces-control-crystallinity.pdf" class="btn btn-sm z-depth-0" role="button">PDF</a> </div> <div class="badges"> <span class="altmetric-embed" data-hide-no-mentions="true" data-hide-less-than="15" data-badge-type="2" data-badge-popover="right"></span> <span class="__dimensions_badge_embed__" data-pmid="" data-hide-zero-citations="true" data-style="small_rectangle" data-legend="hover-right" style="margin-bottom: 3px;"></span> </div> <div class="abstract hidden"> <p>Nanosizing drug crystals has emerged as a successful approach to enabling oral bioavailability, as increasing drug crystal surface area improves dissolution kinetics and effective solubility. Recently, bottom-up methods have been developed to directly assemble nanosized crystals by leveraging polymer and surfactant excipients during crystallization to control crystal size, morphology, and structure. However, while significant research has investigated how polymers and other single additives inhibit or promote crystallization in pharmaceutical systems, there is little work studying the mechanistic interactions of multiple excipients on drug crystal structure and the extent of crystallinity, which can influence formulation performance. This study explores how the structure and crystallinity of a model hydrophobic drug crystal, fenofibrate, change as a result of competitive interfacial chemisorption between common nonionic surfactants (polysorbate 80 and sorbitan monooleate) and a surface-active polymer excipient (methylcellulose). Classical molecular dynamics simulations highlight how key intermolecular interactions, including surfactant-polymer complexation and surfactant screening of the crystal surface, modify the resulting crystal structure. In parallel, experiments generating drug nanocrystals in hydrogel thin films validate that drug crystallinity increases with an increasing weight fraction of surfactant. Simulation results reveal a connection between accelerated dynamics in the bulk crystal and the experimentally measured extent of crystallinity. To our knowledge, these are the first simulations that directly characterize structural changes in a drug crystal as a result of excipient surface composition and relate the experimental extent of crystallinity to structural changes in the molecular crystal. Our approach provides a mechanistic understanding of crystallinity in nanocrystallization, which can expand the range of orally deliverable small molecule therapies.</p> </div> </div> </div> </li></ol> </div> </div> </div> <footer class="fixed-bottom"> <div class="container mt-0"> © Copyright 2025 Lucas Attia. Powered by <a href="https://jekyllrb.com/" target="_blank" rel="external nofollow noopener">Jekyll</a> with <a href="https://github.com/alshedivat/al-folio" rel="external nofollow noopener" target="_blank">al-folio</a> theme. Hosted by <a href="https://pages.github.com/" target="_blank" rel="external nofollow noopener">GitHub Pages</a>. Photos from <a href="https://unsplash.com" target="_blank" rel="external nofollow noopener">Unsplash</a>. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.1/dist/js/bootstrap.bundle.min.js" integrity="sha256-fgLAgv7fyCGopR/gBNq2iW3ZKIdqIcyshnUULC4vex8=" crossorigin="anonymous"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@4/imagesloaded.pkgd.min.js"></script> <script defer src="/assets/js/masonry.js" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.0.8/dist/medium-zoom.min.js" integrity="sha256-7PhEpEWEW0XXQ0k6kQrPKwuoIomz8R8IYyuU1Qew4P8=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js"></script> <script defer src="https://unpkg.com/bootstrap-table@1.21.4/dist/bootstrap-table.min.js"></script> <script src="/assets/js/no_defer.js?d633890033921b33e0ceb13d22340a9c"></script> <script defer src="/assets/js/common.js?acdb9690d7641b2f8d40529018c71a01"></script> <script defer src="/assets/js/copy_code.js?c9d9dd48933de3831b3ee5ec9c209cac" type="text/javascript"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script type="text/javascript">window.MathJax={tex:{tags:"ams"}};</script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.0/es5/tex-mml-chtml.js"></script> <script defer src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script> <script type="text/javascript">function progressBarSetup(){"max"in document.createElement("progress")?(initializeProgressElement(),$(document).on("scroll",function(){progressBar.attr({value:getCurrentScrollPosition()})}),$(window).on("resize",initializeProgressElement)):(resizeProgressBar(),$(document).on("scroll",resizeProgressBar),$(window).on("resize",resizeProgressBar))}function getCurrentScrollPosition(){return $(window).scrollTop()}function initializeProgressElement(){let e=$("#navbar").outerHeight(!0);$("body").css({"padding-top":e}),$("progress-container").css({"padding-top":e}),progressBar.css({top:e}),progressBar.attr({max:getDistanceToScroll(),value:getCurrentScrollPosition()})}function getDistanceToScroll(){return $(document).height()-$(window).height()}function resizeProgressBar(){progressBar.css({width:getWidthPercentage()+"%"})}function getWidthPercentage(){return getCurrentScrollPosition()/getDistanceToScroll()*100}const progressBar=$("#progress");window.onload=function(){setTimeout(progressBarSetup,50)};</script> </body> </html>